Dissecting tumour-immune interactions in mesothelioma for identifying responders to immune checkpoint blockade

被引:0
|
作者
Addala, V. [1 ]
Sneddon, S. [2 ]
Dick, I. [3 ]
Fennell, D. [4 ,5 ]
Pearson, J. V. [6 ]
Robinson, B. [7 ]
Creaney, J. [8 ]
Patch, A-M. [9 ]
Waddell, N. [1 ]
机构
[1] QIMR Berghofer Med Res Inst, Med Genom, Brisbane, Qld, Australia
[2] British Columbia Canc Agcy, Med Genet, Vancouver, BC, Canada
[3] Natl Ctr Asbestos Related Dis, Sch Med, Nedlands, WA, Australia
[4] Univ Leicester, Canc Res UK Ctr Leicester, Thorac Med Oncol, Leicester, Leics, England
[5] Univ Hosp Leicester NHS Trust, Leicester, Leics, England
[6] QIMR Berghofer Med Res Inst, Genome Informat, Brisbane, Qld, Australia
[7] Univ Western Australia, Fac Hlth & Med Sci, Internal Med, Perth, WA, Australia
[8] Univ Western Australia, Fac Hlth & Med Sci, Canc Biol, Perth, WA, Australia
[9] QIMR Berghofer Med Res Inst, Clin Genom, Brisbane, Qld, Australia
关键词
D O I
10.1016/j.annonc.2020.10.577
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
89P
引用
收藏
页码:S1453 / S1453
页数:1
相关论文
共 50 条
  • [1] On a discrete model of tumour-immune system interactions with blockade of immune checkpoints
    Khyat, Toufik
    Jang, Sophia R-J
    [J]. JOURNAL OF DIFFERENCE EQUATIONS AND APPLICATIONS, 2022, 28 (01) : 73 - 108
  • [2] Computational genomics tools for dissecting tumour-immune cell interactions
    Hackl, Hubert
    Charoentong, Pornpimol
    Finotello, Francesca
    Trajanoski, Zlatko
    [J]. NATURE REVIEWS GENETICS, 2016, 17 (08) : 441 - 458
  • [3] Identifying and characterising the impact of excitability in a mathematical model of tumour-immune interactions
    Osojnik, Ana
    Gaffney, Eamonn A.
    Davies, Michael
    Yates, James W. T.
    Byrne, Helen M.
    [J]. JOURNAL OF THEORETICAL BIOLOGY, 2020, 501
  • [4] Immune Checkpoint Blockade in Malignant Mesothelioma
    Calabro, Luana
    Maio, Michele
    [J]. SEMINARS IN ONCOLOGY, 2015, 42 (03) : 418 - 422
  • [5] Tumour-immune cell interactions modulated by chemokines
    Joehrer, Karin
    Pleyer, Lisa
    Olivier, Angelika
    Maizner, Eva
    Zelle-Rieser, Claudia
    Greil, Richard
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (03) : 269 - 290
  • [6] Dissecting Response and Resistance to Immune Checkpoint Blockade
    Liu, David
    [J]. ONCOLOGIST, 2018, 23 : S4 - S4
  • [7] A Validated Mathematical Model of Tumour-Immune Interactions for Glioblastoma
    Toma, Alina
    Castillo, Liliana R. Cisneros
    Schuetz, Tina A.
    Becker, Stefan
    Mang, Andreas
    Regnier-Vigouroux, Anne
    Buzug, Thorsten M.
    [J]. CURRENT MEDICAL IMAGING, 2013, 9 (02) : 145 - 153
  • [8] Combination immune checkpoint blockade as an effective therapy for mesothelioma
    Fear, Vanessa S.
    Tilsed, Caitlin
    Chee, Jonathan
    Forbes, Catherine A.
    Casey, Thomas
    Solin, Jessica N.
    Lansley, Sally M.
    Lesterhuis, W. Joost
    Dick, Ian M.
    Nowak, Anna K.
    Robinson, Bruce W.
    Lake, Richard A.
    Fisher, Scott A.
    [J]. ONCOIMMUNOLOGY, 2018, 7 (10):
  • [9] Combination immune checkpoint blockade as an effective therapy for mesothelioma
    Fisher, S.
    Solin, J.
    Casey, T.
    Lesterhuis, W. J.
    Lansley, S.
    Robinson, B. W. S.
    Lake, R.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 230 - 230
  • [10] Prediction of unfavourable response to checkpoint blockade in lung cancer patients through an integrated tumour-immune expression score
    Liu, Si-Yang Maggie
    Sun, Hao
    Zhou, Jia-Ying
    Zhang, Jia-Tao
    Yin, Kai
    Chen, Zhi-Hong
    Su, Jian
    Zhang, Xu-Chao
    Yang, Jin-Ji
    Zhou, Qing
    Tu, Hai-Yan
    Wu, Yi-Long
    [J]. TRANSLATIONAL ONCOLOGY, 2022, 15 (01):